CNBC's Jim Cramer discusses Dollar General's offer to buy rival retailer Family Dollar in a transaction valued at $9.7 billion.
Activist investor Carl Icahn reported a 6.6 percent stake in Gannett on Thursday, a regulatory filing showed.
Traders attempt to decipher whether the bond market or the stock market is sending the right signal, with the release several key reports Friday.
Carl Icahn has his sights set on splitting up Gannett Co.
He has a very simple model which is to create shareholder value, says Steve MacMillan, Hologic president & CEO, discussing Icahn's stake in Hologic. He's clearly not a micromanager, says MacMillian.
Steve MacMillan, Hologic president & CEO, discusses the company's progress in developing 3D imaging technology. The benefit of this is you can catch the big stuff early, says MacMillian.
CNBC's Bertha Coombs reports Carl Icahn now holds just a 3.61 percent stake in Family Dollar.
CNBC's David Faber looks at shares of Family Dollar after Carl Icahn cut his stake in the company.
Activist investor Carl Icahn said he is hopeful more potential buyers will surface for Family Dollar.
CNBC's David Faber breaks down the deal between Dollar Tree and Family Dollar for about $8.5 billion in cash and stock. Jim Cramer provides insight to the transaction.
Hedge fund billionaire John Paulson netted $1.3 billion on an M&A deal, and Carl Icahn and Bill Ackman are "trading places" on Herbalife, reports CNBC's Kate Kelly.
Bill Ackman fired his latest shot at Herbalife Tuesday, but the company's stock mostly rose during the investor's presentation.
CNBC's Kate Kelly shares highlights from yesterday's Delivering Alpha conference, where many hedge fund managers were hot on the oil boom.
CNBC's Scott Wapner presided over the truce between billionaire Carl Icahn and hedge fund titan Bill Ackman over their Herbalife foray.
CNBC's Kate Kelly shares highlights from Wednesday's Delivering Alpha annual conference, including Ken Griffin's recollections of Citadel's battle back from the brink, and Leon Cooperman's insights on the markets.
Bill Ackman, Pershing Square Capital Management, says he would love for Carl Icahn to take his profits in Herbalife.
Carl Icahn, Icahn Enterprises chairman, and Bill Ackman, Pershing Square Capital Management, share the stage to discuss how they've move past their feud over Herbalife.
Carl Icahn, Icahn Enterprises chairman, says companies need the right people to run them.
Bill Ackman, Pershing Square Capital Management, responds to criticism of his investment style.
Bill Ackman, Pershing Square Capital Management, feels Allergen's attacks are inappropriate.